<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0008242</field><field name="title">LILLY [LLY] CUTS LIPOSOME CO [LIPO] STAKE</field><field name="place">WASHINGTON</field><field name="date">March 31</field><field name="content">- Eli Lilly and Co told the Securities and Exchange Commission it cut its stake in Liposome Co Inc to 500,000 shares, or 4.0 pct of the total outstanding common stock, from 900,000 shares or 7.3 pct.     Lilly said it sold 400,000 Liposome common shares on March 17 at eight dlrs each.     As long as Lilly's stake in Liposome is below five pct, it is not required to report any further dealings it has in the company's stock. </field></doc></add>